Date
February 6, 2025
Reading Time
4 minutes
Share
Vitrectomy is one of the most transformative advancements in modern ophthalmology. Over the decades, this procedure has evolved from rudimentary methods to sophisticated techniques. This article delves into its origins, highlighting the pioneering work of Dr Robert Machemer and Prof Rudolf Klöti, as well as the technological advancements that followed.
The first recorded vitreous surgery was performed in 1863 by Albrecht von Graefe, who used a needle to penetrate the vitreous membrane.
By the 1960s, various experimental techniques had emerged, but most were unsuccessful in achieving long-term results.
In the 1960s, Kasner introduced the "open-sky technique," involving a large limbal incision, corneal removal, and lens extraction to access the vitreous. However, this approach was fraught with complications, including corneal opacities and retinal detachment B2.
In the early 1970s, German-born ophthalmologist Robert Machemer developed the Vitreous Infusion Suction Cutter (VISC). This revolutionary device enabled the safe removal of vitreous humour via the pars plana, reducing intraoperative pressure fluctuations and laying the foundation for modern pars plana vitrectomy B3.
Around the same time, Swiss ophthalmologist Rudolf Klöti advanced vitrectomy technology by focusing on miniaturising instruments and refining surgical techniques. Together with Heinz Oertli, the founder of Oertli Instrumente AG, Klöti developed the “Vitreous Stripper,” a revolutionary vitrectomy cutter that integrated aspiration, cutting, and infusion into a single instrument. This device became the gold standard in vitreous surgery, enabling safer and more precise procedures.
Heinz Oertli, who established his workshop in St. Gallen in 1955, brought decades of experience in crafting ophthalmic instruments. His early innovations, including tools for strabismus and corneal surgeries, laid the groundwork for the collaboration with Klöti. Together, they not only designed the Vitreous Stripper but also pioneered advancements such as diathermy instruments, peristaltic pumps, and light-guiding systems. These tools significantly enhanced surgical precision and efficiency, setting new standards for vitreoretinal procedures B4 B5.
Initially, only a linear pedal was available, allowing control over just one parameter at a time. In 1985, Oertli Instrumente AG introduced the dual-linear pedal, enabling independent control of two parameters, e.g., pump system and vitrectomy cutting rate.
Since its introduction in 2008, Oertli’s trocar system has continued to evolve. The current Caliburn Trocar System combines a sharp, lance-shaped blade, bevelled cannula design, tactile markings and an integrated 4-flap self-sealing membrane to support smooth trocar placement.
Klöti and Oertli’s combined efforts marked a turning point in the field, demonstrating the power of interdisciplinary collaboration between surgeons and instrument makers. Their work laid the foundation for modern micro-incision vitrectomy surgery (MIVS), highlighting how innovation and partnership can transform patient care.
The technological advancements in vitrectomy have unfolded over several stages:
The future of vitrectomy holds exciting possibilities, driven by ongoing technological and scientific innovations. Future ophthalmic instruments may enable surgeries with minimal tissue disruption and faster recovery times. Advanced imaging technologies, such as intraoperative optical coherence tomography (OCT) and 3D visualisation systems, could offer unparalleled precision during procedures.
The integration of robotics and artificial intelligence (AI) may also redefine surgical practices. Robots could assist with ultra-precise tasks, while AI algorithms could provide real-time decision support by analyzing imaging data during surgery. Additionally, bioengineered solutions, such as artificial vitreous substitutes or new materials for ocular repair, may further expand treatment options..
Collaboration across disciplines like engineering, biotechnology, and materials science will likely accelerate these developments. As these technologies mature, they could pave the way for safer, more efficient, and even preventive approaches to vitreoretinal care.
While the specifics of these advancements remain uncertain, the trajectory of innovation in vitreoretinal surgery is clear. By building on the legacy of pioneers like Machemer and Klöti, the field continues to evolve, bringing hope to patients and setting the stage for a future where vision restoration becomes even more accessible and precise B1.
Share
